GCT participated in a live webinar “Generics in the EAEU: The New Reality”
The pharmaceutical market is a complex and dynamic system, which is guided by ever-changing laws, regulations, and policies.
GCT team keeps up with the latest updates by taking part in industry conferences, webinars, and other events in order to provide the highest quality of service to our partners.
Irina Golovacheva, MD, Deputy Director of Regulatory Affairs at GCT, participated in a live webinar titled “Generics in the EAEU: The New Reality”. Dr. Golovacheva enjoyed the applicable and detailed information on the issues in interchangeability, governmental regulations of generics, and trials of bioequivalence, which she received during the online event.
Contact firstname.lastname@example.org for regulatory advice from a GCT specialist.
Updated: March 19, 2021